Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Screenings. A board-certified dermatologist travels to the fire station to provide free skin cancer screenings through the ...

A national survey highlighted scars, acne, and hyperhidrosis as the most commonly treated pediatric cosmetic conditions, with ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea ... Corporation (Nasdaq: DERM) (“Journey Medical ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...

Wound healing is a core skill in dermatology, but true expertise involves incorporating new techniques with the medical school basics to address challenging cases.

Researchers at The University of Sydney have identified a significant increase in melanoma-related death risk for patients ...

We’ve rounded up the best dermatologist-approved, fragrance-free moisturizers for your psoriasis skin care routine.